TNL Mediagene (TNMG)
NASDAQ:TNMG
Want to see TNMG full AI Analyst Report?
Top Page
TNL Mediagene
(NASDAQ:TNMG)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.51
▼(-60.85% Downside)
Action:Reiterated
Date:06/17/26
The score is primarily constrained by weak financial performance (deep losses, persistent cash burn, and sharply deteriorated equity/leverage). Technicals add further downside risk due to a clear downtrend and negative momentum. Valuation provides limited support because negative earnings make P/E less informative and there is no dividend yield.
Positive Factors
Long-term contracts in digital studio
The digital studio unit generated $18.7M and is supported by long-term contracts and public-sector work. Those contract tails provide durable revenue visibility, reduce churn risk, and anchor cash generation while the company pivots its portfolio and scales AI-enabled services over coming quarters.
Negative Factors
Nasdaq minimum equity shortfall
Equity fell well below Nasdaq’s minimum, triggering a deficiency letter and a compliance process. Restoring compliance likely requires capital raises or asset disposals, which can be dilutive or strategic-constraining, and creates execution pressure that affects longer-term investment and M&A optionality.
Read all positive and negative factors
Positive Factors
Negative Factors
Long-term contracts in digital studio
The digital studio unit generated $18.7M and is supported by long-term contracts and public-sector work. Those contract tails provide durable revenue visibility, reduce churn risk, and anchor cash generation while the company pivots its portfolio and scales AI-enabled services over coming quarters.
Read all positive factors
TNL Mediagene (TNMG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.30M
Dividend YieldN/A
Average Volume (3M)11.02M
Price to Earnings (P/E)―
Beta (1Y)2.67
Revenue Growth-7.16%
EPS Growth71.12%
CountryUS
Employees500
SectorHealthcare
Sector Strength45
IndustryPublishing
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,556,405
10 Day Avg. Volume12,249,583
30 Day Avg. Volume11,015,397
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)5.11
Price to Sales (P/S)0.10
P/FCF Ratio-0.89
Enterprise Value/Market Cap15.73
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit1.17
Enterprise Value/Ebitda-2.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TNL Mediagene Business Overview & Revenue Model
Company Description
TNL Mediagene is a prominent media firm with operations spanning Taiwan and Japan. The company boasts an extensive portfolio of digital publications and platforms. These include general news outlets like The News Lens and Sirabee (covering enterta...
How the Company Makes Money
TNMG primarily makes money by monetizing its digital audiences and content through advertising and brand marketing services. Key revenue streams typically include: (1) Digital advertising sales on its owned media properties (e.g., display ads and ...
TNL Mediagene Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
22
Negative
Cash Flow
15
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 45.02M | 48.49M | 35.84M | 20.01M |
| Gross Profit | 13.98M | 17.74M | 12.65M | 7.74M |
| EBITDA | -7.08M | -73.92M | 1.33M | -10.01M |
| Net Income | -44.55M | -85.00M | -804.98K | -11.01M |
Balance Sheet | ||||
| Total Assets | 49.95M | 92.92M | 119.62M | 26.53M |
| Cash, Cash Equivalents and Short-Term Investments | 2.91M | 3.65M | 3.03M | 3.91M |
| Total Debt | 21.62M | 23.14M | 17.59M | 6.71M |
| Total Liabilities | 49.03M | 56.51M | 47.25M | 50.67M |
| Stockholders Equity | 919.25K | 36.40M | 72.62M | -25.30M |
Cash Flow | ||||
| Free Cash Flow | -5.30M | -10.30M | -1.68M | -1.04M |
| Operating Cash Flow | -4.90M | -10.21M | -1.42M | -760.11K |
| Investing Cash Flow | -897.27K | 947.95K | 252.74K | -2.36M |
| Financing Cash Flow | 3.93M | 10.00M | 530.97K | 4.99M |
TNL Mediagene Technical Analysis
Negative
1.29
Price Trends
0.86
Negative
1.76
Negative
3.60
Negative
Market Momentum
-0.10
Negative
33.97
Neutral
5.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TNMG, the sentiment is Negative. The current price of 1.29 is above the 20-day moving average (MA) of 0.65, above the 50-day MA of 0.86, and below the 200-day MA of 3.60, indicating a bearish trend. The MACD of -0.10 indicates Negative momentum. The RSI at 33.97 is Neutral, neither overbought nor oversold. The STOCH value of 5.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TNMG.
TNL Mediagene Risk Analysis
TNL Mediagene disclosed 54 risk factors in its most recent earnings report. TNL Mediagene reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
TNL Mediagene Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $3.67M | -2.94 | -50.26% | ― | -75.33% | 75.98% | |
44 Neutral | $8.94M | -6.08 | ― | ― | ― | ― | |
43 Neutral | $2.00M | -0.08 | ― | ― | -31.04% | 49.18% | |
41 Neutral | $1.30M | -0.01 | -164.27% | ― | -7.16% | 71.12% | |
| ― | $6.72M | -6.05 | -194.72% | ― | -8.74% | 88.46% |
* Healthcare Sector Average
TNMG
TNL Mediagene
0.51
-10.90
-95.55%
CNET
ZW Data Action Technologies
1.00
-0.35
-25.93%
BAOS
Baosheng Media Group Holdings
2.77
0.07
2.59%
DRCT
Direct Digital Holdings
2.85
-112.39
-97.53%
VSME
VS Media Holdings Limited Class A
2.43
-17.15
-87.59%
FTRK
Fast Track Group
0.41
-5.99
-93.59%
TNL Mediagene Corporate Events
TNL Mediagene Warned by Nasdaq Over Minimum Equity Shortfall
May 12, 2026
On May 12, 2026, TNL Mediagene disclosed that it received a Nasdaq deficiency letter dated May 6, 2026, after reporting stockholders’ equity of $918,088 in its FY2025 Form 20-F, below the $2.5 million minimum required under Listing Rule 5550...
TNL Mediagene Files FY2025 20-F, Narrows Net Loss but Warns on Going Concern
May 12, 2026
On May 12, 2026, TNL Mediagene reported its financial results for the year ended December 31, 2025, highlighting that its digital studio unit remained the largest revenue contributor with $18.7 million, or 41.4% of total revenue, supported by long...
TNL Mediagene Overhauls Leadership and Unveils 2026 AI-Focused Strategy
Apr 2, 2026
On April 2, 2026, TNL Mediagene announced a leadership reshuffle that elevates Motoko Imada to Chief Executive Officer while she retains the Chief Operating Officer role, giving her full operational authority over profit and loss, budgets, and glo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.